Thought leadership, whitepapers, and case studies from the Bracy Analytics team — covering AI/ML in clinical research, regulatory science, and healthcare data.
4 posts
Machine learning is reshaping how pharmaceutical and biotech companies extract insight from clinical trial data — faster, more accurately, and at a scale that was previously impossible.
Automated CDISC programming tools promise to compress submission timelines and reduce errors. Here is an honest assessment of where automation delivers and where human expertise remains essential.
Real-world evidence has become central to payer coverage decisions. Here is what separates RWE packages that succeed from those that get rejected — and how to build the former.
Natural language processing can dramatically accelerate adverse event narrative coding — but only if it is implemented with the rigor that pharmacovigilance and regulatory review demand.